This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Doug Brooks, PhD
Principal Consultant at Matapalo LLC


Doug has over 25 years working in the oligonucleotide industry and has served on the TIDES Scientific Advisory Panel since 2008. After completing his graduate studies at UC Santa Cruz, he joined Ionis Pharmaceuticals. Through the years he has worked at several therapeutic Oligo companies developing CMC strategy and overseeing technical operations. He has contributed to multiple regulatory CMC submissions in multiple countries. In 2018, he established Matapalo Pharmaceutical Consulting Services located in Carlsbad, California.

Agenda Sessions

  • Chairperson's Remarks: Oligonucleotide Development and Manufacturing